Advaxis Finds Alternative Funding In Animal Health Deal
This article was originally published in The Pink Sheet Daily
Executive Summary
Advaxis has teamed up with pet therapeutics company Aratana to develop its human immunotherapy in companion animal indications and intends to use the funding to further human clinical development.